American Heart Association
New Targets and New Treatments: Advances in Lipid Therapeutics
Late-Breaking Science
Main Event I
Nov 18th , 01:30 PM - 02:45 PM
Rader Daniel, Morris Pamela
Final Pr. ID: -
Authors: Rader Daniel, Morris Pamela
01 : 40 PM
ALPACAR Phase 2 Trial of Zerlasiran: Multiple doses of a Small-Interfering RNA Targeting Lipoprotein(a) with 60 weeks Folow Up.
Nissen Steven, Dorresteijn Jannick, Fok Henry, Rider David, Romano Steve, Wolski Kathy, Rambaran Curtis, Wang Qiuqing, Nicholls Stephen, Navar Ann Marie, Ray Kausik, Schwartz Gregory, Szarek Michael, Stroes Erik, Troquay Roland
Final Pr. ID: 4158676
Authors: Nissen Steven, Dorresteijn Jannick, Fok Henry, Rider David, Romano Steve, Wolski Kathy, Rambaran Curtis, Wang Qiuqing, Nicholls Stephen, Navar Ann Marie, Ray Kausik, Schwartz Gregory, Szarek Michael, Stroes Erik, Troquay Roland
Keywords: Apolipoproteins , Atherosclerosis , Lipids
01 : 52 PM
A Randomized Phase 2 Trial of Muvalaplin: An Oral Disrupter of the Assembly of Lipoprotein(a) Particles
Nicholls Stephen, Ni Wei, Rhodes Grace, Nissen Steven, Navar Ann Marie, Michael Laura, Krege John
Final Pr. ID: 4171286
Authors: Nicholls Stephen, Ni Wei, Rhodes Grace, Nissen Steven, Navar Ann Marie, Michael Laura, Krege John
Keywords: Lipoproteins , Lipids , Clinical trials , Cardiovascular disease prevention
Tokgozoglu Lale, Goldberg Anne
Final Pr. ID: -
Authors: Tokgozoglu Lale, Goldberg Anne
02 : 14 PM
Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
Nicholls Stephen, Brunham Liam, Wuerdeman Erin, Neild Annie, Kling Douglas, Hsieh Andrew, Ference Brian, Laufs Ulrich, Banach Maciej, Mehran Roxana, Catapano Alberico, Nelson Adam, Davidson Michael, Ditmarsch Marc, Kastelein John, Ballantyne Christie, Ray Kausik, Navar Ann Marie, Nissen Steven, Goldberg Anne
Final Pr. ID: 4171281
Authors: Nicholls Stephen, Brunham Liam, Wuerdeman Erin, Neild Annie, Kling Douglas, Hsieh Andrew, Ference Brian, Laufs Ulrich, Banach Maciej, Mehran Roxana, Catapano Alberico, Nelson Adam, Davidson Michael, Ditmarsch Marc, Kastelein John, Ballantyne Christie, Ray Kausik, Navar Ann Marie, Nissen Steven, Goldberg Anne
Keywords: CETP inhibitors , Lipids , Clinical trials , Dyslipidemia , Prevention
Watson Karol
Final Pr. ID: -
Authors: Watson Karol
01 : 52 PM
A Randomized Phase 2 Trial of Muvalaplin: An Oral Disrupter of the Assembly of Lipoprotein(a) Particles
Nicholls Stephen, Ni Wei, Rhodes Grace, Nissen Steven, Navar Ann Marie, Michael Laura, Krege John
Final Pr. ID: 4171286
Authors: Nicholls Stephen, Ni Wei, Rhodes Grace, Nissen Steven, Navar Ann Marie, Michael Laura, Krege John
Keywords: Lipoproteins , Lipids , Clinical trials , Cardiovascular disease prevention
01 : 40 PM
ALPACAR Phase 2 Trial of Zerlasiran: Multiple doses of a Small-Interfering RNA Targeting Lipoprotein(a) with 60 weeks Folow Up.
Nissen Steven, Dorresteijn Jannick, Fok Henry, Rider David, Romano Steve, Wolski Kathy, Rambaran Curtis, Wang Qiuqing, Nicholls Stephen, Navar Ann Marie, Ray Kausik, Schwartz Gregory, Szarek Michael, Stroes Erik, Troquay Roland
Final Pr. ID: 4158676
Authors: Nissen Steven, Dorresteijn Jannick, Fok Henry, Rider David, Romano Steve, Wolski Kathy, Rambaran Curtis, Wang Qiuqing, Nicholls Stephen, Navar Ann Marie, Ray Kausik, Schwartz Gregory, Szarek Michael, Stroes Erik, Troquay Roland
Keywords: Apolipoproteins , Atherosclerosis , Lipids
Watson Karol
Final Pr. ID: -
Authors: Watson Karol
Tokgozoglu Lale, Goldberg Anne
Final Pr. ID: -
Authors: Tokgozoglu Lale, Goldberg Anne
Rader Daniel, Morris Pamela
Final Pr. ID: -
Authors: Rader Daniel, Morris Pamela
02 : 14 PM
Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
Nicholls Stephen, Brunham Liam, Wuerdeman Erin, Neild Annie, Kling Douglas, Hsieh Andrew, Ference Brian, Laufs Ulrich, Banach Maciej, Mehran Roxana, Catapano Alberico, Nelson Adam, Davidson Michael, Ditmarsch Marc, Kastelein John, Ballantyne Christie, Ray Kausik, Navar Ann Marie, Nissen Steven, Goldberg Anne
Final Pr. ID: 4171281
Authors: Nicholls Stephen, Brunham Liam, Wuerdeman Erin, Neild Annie, Kling Douglas, Hsieh Andrew, Ference Brian, Laufs Ulrich, Banach Maciej, Mehran Roxana, Catapano Alberico, Nelson Adam, Davidson Michael, Ditmarsch Marc, Kastelein John, Ballantyne Christie, Ray Kausik, Navar Ann Marie, Nissen Steven, Goldberg Anne
Keywords: CETP inhibitors , Lipids , Clinical trials , Dyslipidemia , Prevention